Cancer Research Society: Translational Research Partnership Program
Research Admin Offices:
- ROADS|HRS
Funding Type:
GrantValue:
A maximum of $1,500,000 over up to 3 years per project of which up to 50% may come from the Cancer Research Society.
Disciplines:
- Health Sciences
Sponsors:
- Canadian Cancer Society
Deadlines:
Internal Deadline:
ContinuousSponsor Deadline:
ContinuousDescription:
The Translational Research Partnership Program supports collaborative projects in cancer research to help accelerate the development of new treatments and/or technologies for the benefit of patients. Our Translational Research Partnership strategy is bold and ambitious. We aim to break down the boundaries between research disciplines, which may include researchers from non-cancer backgrounds, in order to find innovative solutions to prevent, detect and treat cancer. We partner with a range of organizations to maximize the impact of research on patient outcomes.
Projects must meet the following conditions:
- Be translational research and may include clinical trial studies
- Basic research projects are out of scope
- Aim the development of a therapeutic and/or novel technologies
- Have excellent preliminary data to support the proposed project
Eligibility:
The research team must consist of at least one principal investigator and one co-investigator. The inclusion of a variety of non-cancer disciplines is encouraged to drive the development of novel technologies and to take thinking from other fields that have not yet been applied to cancer.
All projects are evaluated based on the following criteria:
- Scientific excellence and innovativeness of proposed project
- Expertise of the multidisciplinary team
- Quality of preliminary data and feasibility
- Financial partner’s engagement
- Anticipated benefits for cancer patients
Application/Nomination Process:
Selection Criteria
All projects are evaluated based on the following criteria:
- Scientific excellence and innovativeness of proposed project
- Expertise of the multidisciplinary team
- Quality of preliminary data and feasibility
- Financial partner’s engagement
- Anticipated benefits for cancer patients
Resources:
Contact:
If you are applying from the Faculty of Health Sciences, please contact an Advisor from HRS. For support with external non-industry funding, please contact Virginia Viscardi, Senior Advisor, ROADS.